Dimerized Mps1 and Spc105/KNL1 for SAC Activation

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Breakdown of the spindle assembly checkpoint (SAC) leads to genetic instability and aneuploidy, contributing to tumorigenesis and cancer, necessitating compositions and methods to activate the SAC for accurate chromosome segregation.

Innovation Solution

Dimerized Mps1 and Spc105/KNL1 constructs are developed as tunable activators of the SAC, facilitating phosphorylation and enhancing chromosome segregation accuracy.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Manufacturing precision

If the spindle assembly checkpoint (SAC) is activated using dimerized Mps1 and Spc105/KNL1 constructs, then chromosome segregation accuracy is improved and aneuploidy is prevented, but the complexity of the system increases due to the need for dimerization elements and controlled interactions

Engineering Contradiction:
Improvechromosome segregation accuracyVSAvoidsystem complexity
Core Design Contradiction:
Manufacturing precisionVSDevice complexity

Solution Approach 1:

The system is divided into separate functional modules: Mps1 kinase domain, Spc105/KNL1 phosphodomain, and dimerization elements (FRB and FKBP). These segments can be independently expressed and controlled, allowing precise activation of the SAC pathway only when needed through induced dimerization, thereby achieving high chromosome segregation accuracy without permanent system complexity

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The dimerization elements FRB and FKBP act as intermediaries that control the interaction between Mps1 and Spc105/KNL1. By using small molecule inducers (like rapamycin) to trigger dimerization, the system achieves controlled activation of the SAC pathway, improving chromosome segregation accuracy while maintaining system simplicity through conditional assembly rather than constitutive complex formation

Inventive Principle:
Principle #24Intermediary (Mediator)

2Reliability

If dimerization elements are introduced to control Mps1 and Spc105/KNL1 interaction, then activation control of SAC is improved, but the quantity of components increases

Engineering Contradiction:
ImproveSAC activation controlVSAvoidnumber of components
Core Design Contradiction:
ReliabilityVSQuantity of substance

Solution Approach 1:

The functional domains (Mps1 kinase, Spc105/KNL1 phosphodomain) are merged with dimerization elements (FRB or FKBP) into single polypeptide constructs. This merging reduces the total number of separate components needed while maintaining reliable SAC activation control, as each fusion protein contains both the functional activity and the dimerization capability in one molecule

Inventive Principle:
Principle #5Merging (Combining)

Solution Approach 2:

The dimerization elements FRB and FKBP serve multiple functions: they mediate controlled protein-protein interaction, provide a platform for inducible complex formation, and enable temporal control of SAC activation. This multi-functionality reduces the need for additional specialized components while improving activation control reliability

Inventive Principle:
Principle #6Universality (Multi-functionality)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The dimerized constructs effectively prevent aneuploidy by activating the SAC, offering a potential treatment for cancer by maintaining chromosome stability.

Implementation Method 1

dimerization of the first dimerization element and second dimerization element facilitates phosphorylation of the Spc105/KNL1 polypeptide by the Mps1 polypeptide

Methodology Applied
Scientific EffectPhosphorylation:

Data Source

PatentUS12454559B2Activating mitotic checkpoint control mechanisms
Publication Date: 2025.10.28 THE RGT UNIV OF MICHIGAN
  • US12454559B2 patent drawing
  • US12454559B2 patent drawing
  • US12454559B2 patent drawing

AI summary

Provided herein are compositions and methods for the treatment of cancer by activating the spindle assembly checkpoint (SAC) in cells. In particular, dimerized Mps1 and Spc105/KNL1 constructs are provided as tunable activators of SAC, allowing for control of chromosome segregation accuracy and prevention of aneuploidies that are common in cancer.